Goldman Sachs’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45M | Buy |
3,242,077
+339,808
| +12% | +$5.41M | 0.01% | 1666 |
|
|
2025
Q4 | $47.1M | Buy |
2,902,269
+1,022,417
| +54% | +$16.7M | 0.01% | 1551 |
|
|
2025
Q3 | $28.1M | Sell |
1,879,852
-47,591
| -2% | -$580K | ﹤0.01% | 1919 |
|
|
2025
Q2 | $22.5M | Sell |
1,927,443
-78,001
| -4% | -$708K | ﹤0.01% | 2026 |
|
|
2025
Q1 | $14.9M | Sell |
2,005,444
-232,682
| -10% | -$1.79M | ﹤0.01% | 2311 |
|
|
2024
Q4 | $13.4M | Buy |
2,238,126
+488,979
| +28% | +$2.7M | ﹤0.01% | 2511 |
|
|
2024
Q3 | $8.96M | Buy |
1,749,147
+701,135
| +67% | +$3.05M | ﹤0.01% | 2834 |
|
|
2024
Q2 | $3.79M | Buy |
1,048,012
+421,291
| +67% | +$1.34M | ﹤0.01% | 3412 |
|
|
2024
Q1 | $2.01M | Sell |
626,721
-177,339
| -22% | -$686K | ﹤0.01% | 3859 |
|
|
2023
Q4 | $3.94M | Sell |
804,060
-893,114
| -53% | -$4.08M | ﹤0.01% | 3367 |
|
|
2023
Q3 | $9.25M | Sell |
1,697,174
-452,056
| -21% | -$2.99M | ﹤0.01% | 2456 |
|
|
2023
Q2 | $14.4M | Buy |
2,149,230
+649,493
| +43% | +$4.83M | ﹤0.01% | 2121 |
|
|
2023
Q1 | $13.2M | Buy |
1,499,737
+209,162
| +16% | +$1.84M | ﹤0.01% | 2169 |
|
|
2022
Q4 | $9.86M | Sell |
1,290,575
-616,014
| -32% | -$4.79M | ﹤0.01% | 2600 |
|
|
2022
Q3 | $13.6M | Buy |
1,906,589
+566,107
| +42% | +$5.33M | ﹤0.01% | 2218 |
|
|
2022
Q2 | $10.8M | Buy |
1,340,482
+164,380
| +14% | +$1.45M | ﹤0.01% | 2442 |
|
|
2022
Q1 | $16.3M | Sell |
1,176,102
-143,271
| -11% | -$2.25M | ﹤0.01% | 2223 |
|
|
2021
Q4 | $37M | Buy |
1,319,373
+47,975
| +4% | +$1.47M | 0.01% | 1592 |
|
|
2021
Q3 | $43.2M | Sell |
1,271,398
-107,367
| -8% | -$3.88M | 0.01% | 1390 |
|
|
2021
Q2 | $56.3M | Buy |
1,378,765
+247,166
| +22% | +$9.61M | 0.02% | 1149 |
|
|
2021
Q1 | $45.6M | Buy |
1,131,599
+272,217
| +32% | +$14.7M | 0.01% | 1239 |
|
|
2020
Q4 | $50.8M | Sell |
859,382
-392,043
| -31% | -$20.2M | 0.02% | 1117 |
|
|
2020
Q3 | $60.9M | Buy |
1,251,425
+121,232
| +11% | +$5.1M | 0.02% | 857 |
|
|
2020
Q2 | $54.7M | Buy |
1,130,193
+522,605
| +86% | +$19.1M | 0.02% | 889 |
|
|
2020
Q1 | $16.9M | Buy |
607,588
+157,695
| +35% | +$4.4M | 0.01% | 1641 |
|
|
2019
Q4 | $13.5M | Buy |
449,893
+202,183
| +82% | +$5.81M | ﹤0.01% | 2203 |
|
|
2019
Q3 | $7.66M | Buy |
247,710
+95,581
| +63% | +$3.9M | ﹤0.01% | 2533 |
|
|
2019
Q2 | $7.35M | Buy |
+152,129
| New | +$6.74M | ﹤0.01% | 2589 |
|
Other funds holding ADPT
VCM
VPM
